1.
Dolores J. Schendel. Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia?. Haematologica 2012;97(10):1454-1455; https://doi.org/10.3324/haematol.2012.077099.